Qube Research & Technologies (QRT)’s Cabaletta Bio CABA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.44M	Sell	1,426,840 -508,150	-26%	-$1.67M	﹤0.01%	1694
2026 Q1	$5.21M	Buy	1,934,990 +1,603,765	+484%	+$4.45M	0.01%	1625
2025 Q4	$725K	Buy	331,225 +242,068	+272%	+$600K	﹤0.01%	2684
2025 Q3	$209K	Buy	+89,157	New	+$153K	﹤0.01%	2936
2024 Q4	–	Sell	-230,293	Closed	-$1.09M	–	3478
2024 Q3	$1.09M	Sell	230,293 -73,033	-24%	-$423K	﹤0.01%	2001
2024 Q2	$2.27M	Sell	303,326 -131,174	-30%	-$1.61M	﹤0.01%	1564
2024 Q1	$7.41M	Buy	434,500 +382,301	+732%	+$8.21M	0.01%	1003
2023 Q4	$1.18M	Buy	+52,199	New	+$878K	﹤0.01%	1831
2022 Q1	–	Sell	-14,497	Closed	-$55K	–	2476
2021 Q4	$55K	Buy	+14,497	New	+$155K	﹤0.01%	2240

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CABA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Cabaletta Bio (CABA) stake by 26% in Q2 2026, selling an estimated $1.67M and leaving 1,426,840 shares worth $4.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1694.

Qube Research & Technologies (QRT) first reported a position in CABA in Q4 2021 and has held it in 9 quarters since. The position peaked at $7.41M in Q1 2024. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Qube Research & Technologies (QRT) held 1,426,840 shares of Cabaletta Bio worth $4.44M as of Q2 2026.
Qube Research & Technologies (QRT) sold 508,150 Cabaletta Bio shares in Q2 2026, an estimated $1.67M.
Cabaletta Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1694 holding.
Qube Research & Technologies (QRT) first reported a position in Cabaletta Bio in Q4 2021 and has held it in 9 quarters since.
Qube Research & Technologies (QRT)'s Cabaletta Bio position peaked at $7.41M in Q1 2024.
140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.